Declining Cancer Screening Rates Prompt Interest in New Detection Methods
A survey indicates a decline in cancer screening rates, contrasted by growing interest in at-home and multi-cancer early detection tests.
Read MorePosted by Editorial Staff | Jul 28, 2025 | Cancer |
A survey indicates a decline in cancer screening rates, contrasted by growing interest in at-home and multi-cancer early detection tests.
Read MorePosted by Chris Wolski | Jul 24, 2025 | Hematology & Serology |
MeMed has unveiled MeMed BV Flex, a rapid fingerstick-based test that distinguishes bacterial from viral infections in 15 minutes.
Read MorePosted by Chris Wolski | Jul 23, 2025 | Molecular Diagnostics |
Natera has received two new FDA Breakthrough Device Designations for its personalized Signatera ctDNA test.
Read MorePosted by Chris Wolski | Jul 23, 2025 | Womens Health |
Researchers have developed a highly sensitive, pregnancy-test-like diagnostic device that uses menstrual blood to detect endometriosis early.
Read MorePosted by Chris Wolski | Jul 21, 2025 | Cancer |
A new survey reveals declining cancer screening rates among U.S. adults, but shows strong interest in innovative screening methods.
Read More